Pricing

Karyopharm Therapeutics Inc (KPTI)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard A. Paulson
Employees:
380
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
617-658-0600
Karyopharm Therapeutics Inc. discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available